Hepatitis C therapy with HCV NS5B polymerase inhibitors

Author： Soriano Vincent   Vispo Eugenia   de Mendoza Carmen   Labarga Pablo   Fernandez-Montero Jose Vicente   Poveda Eva   Treviño Ana   Barreiro Pablo  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.14, Iss.9, 2013-06, pp. : 1161-1170

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New NS5B polymerase inhibitors for hepatitis C

By Legrand-Abravanel Florence   Nicot Florence   Izopet Jacques  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 8, 2010-08 ,pp. : 963-975

Informa Healthcare

Access to resources Recommend Favorite

Allosteric Inhibitors of Hepatitis C NS5B RNA-dependent RNA Polymerase°

By  

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 4, Iss. 2, 2005-04 ,pp. : 99-110

Bentham Science Publishers

Access to resources Recommend Favorite

Nucleoside Inhibitors of Hepatitis C Virus NS5B Polymerase: A Systematic Review

By  

Current Drug Targets, Vol. 17, Iss. 13, 2016-09 ,pp. : 1560-1576

Bentham Science Publishers

Access to resources Recommend Favorite

NS5B RNA Dependent RNA Polymerase Inhibitors: The Promising Approach to Treat Hepatitis C Virus Infections

By  

Current Medicinal Chemistry, Vol. 17, Iss. 32, 2010-11 ,pp. : 3806-3826

Bentham Science Publishers

Access to resources Recommend Favorite

Design and Synthesis of Amino Acid Tethered Thiazolones to Screen for Hepatitis C NS5B Polymerase Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 14, Iss. 12, 2017-10 ,pp. : 1376-1381

Bentham Science Publishers

Access to resources Recommend Favorite